Posted inBiotechnology
Urban Social Capital: Bogotá’s Cable Car Impact
In the sprawling megacity of Bogotá, a groundbreaking urban intervention has cast new light on the intricate social fabric woven…
Posted inBiotechnology
Neonatal Outcomes Linked to Maternal Red Cell Transfusions
In a groundbreaking study published in the Journal of Perinatology, researchers have delved deep into the intricate relationship between maternal…
Posted inBiotechnology
Decoding DNA Methylation and Gene Expression in Early Pregnancy
In a breakthrough study published in BMC Genomics, researchers have conducted an integrated analysis of DNA methylation and gene expression…
Posted inBiotechnology
Eight-Year CMSAR Follow-Up: New MDS Criteria Impact
In a groundbreaking longitudinal study published in npj Parkinson’s Disease, Soriano, Painous, Fernandez, and their colleagues present an extensive eight-year…
Posted inBiotechnology
Surgery Type Influences Nutrition Duration in NEC Infants
In the evolving landscape of neonatal surgery, a groundbreaking study set to reshape the management of surgical necrotizing enterocolitis (NEC)…
Posted inBiotechnology
Skin-Implanted Living Sensor Enables Long-Term Biomarker Tracking
In a groundbreaking convergence of biotechnology and wearable technology, researchers have unveiled an extraordinary innovation: a living sensor display that…
Posted inBiotechnology
Prenatal Metals, Genes Linked to Birth Size in Taiwan
The Intricate Interplay of Prenatal Metal Exposure, Genetics, and Birth Size: A Groundbreaking Study from Taiwan Emerging research continuously reveals…
Posted inBiotechnology
Early Parkinson’s Subtypes Identified via EEG-Gait Fusion
In a groundbreaking study poised to reshape the clinical landscape of Parkinson’s disease diagnosis and management, researchers have harnessed the…
Posted inMedical Technology
Thermo Fisher Scientific teams up with Nvidia, TetraScience for next-gen AI workflow projects
Thermo Fisher Scientific is starting 2026's J.P. Morgan Healthcare Conference with a bang, announcing two new deals with an artificial…
Posted inBiotechnology
AbbVie pens $5.6B pact with RemeGen to join PD-1xVEGF bispecific battle
AbbVie has made no secret of the fact that it’s taken an interest in the hotly contested PD-1xVEGF bispecific space.…